A single amino acid change in a protein (TKTL1) may have given modern humans an advantage over their older contemporaries, such as Neanderthals, by allowing greater neocortical neuronal formation, according to research published in Science.
Researchers have tested a gonadotropin-releasing hormone (GnRH) therapy in mouse models and in males (in a pilot clinical trial) with Down's syndrome. The results, published in the journal Science, suggest improved cognitive function.
A study published in Cell Reports shows that air pollution and stress during pregnancy disrupt the brain wiring of developing male and not female mice, causing autism-like social behavior in them.
Compared to Neanderthals and apes, modern humans experience fewer chromosomal inheritance errors when their brains develop, according to a new study published in Science Advances.
A study published today in the Journal of Neurology Neurosurgery & Psychiatry claims that some drugs used to treat attention deficit hyperactivity disorder (ADHD) may also help with some symptoms of Alzheimer's disease.
Lamivudine, a commonly used antiretroviral drug for the treatment of HIV, improves cognitive ability in a mouse model of Down's syndrome, according to a new study published today in the Journal of Cellular and Molecular Medicine.
Brain lesions that cause spontaneous remission of tobacco addiction in humans affect a brain circuit common to different addictive behaviours, concludes a study published in Nature Medicine. Understanding this brain network opens the way to new therapies against addiction.
Cerebrospinal fluid provides nutrients and other elements to brain cells. Scientists now show that by obtaining it from young mice and injecting it into the brains of old mice, the latter recover their memory. The effect is attributed to a protein, Fgf17, presented today in Nature as a possible brain rejuvenation factor.
A study of 32 million adults in England has shown a small increase in the risk of suffering from Guillain-Barré syndrome and Bell's palsy, two neurological conditions, after receiving AstraZeneca's vaccine. There was also an increased risk of stroke after receiving Pfizer's vaccine. However, according to the paper, these side effects are rare and the chances of suffering them are much higher after SARS-CoV-2 infection.